Pharma's mobile apps have tended to focus on Apple's iPhone and, to a lesser extent, its iPad, but Android apps are also being produced
The launch of the MHRA-approved Mersey Burns app and Pfizer's withdrawal of its Rheumatology calculator app should change the way pharma thinks about mobile technology
When it comes to mobile devices diabetes has proved a popular therapy with Sanofi and Bayer
Industry apps have easily outnumbered pharma mobile websites
Companies are keen to harness the tablet’s usability to increase their sales teams' effectiveness